Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Lung Cancer Surgery Market Forecast: Value Set To Climb From $5.6 Billion To $6.73 Billion
The lung cancer surgery market size has demonstrated robust expansion in recent years. It is anticipated to increase from $5.33 billion in 2025 to $5.6 billion in 2026, registering a compound annual growth rate (CAGR) of 5.1%. This historical growth can be linked to several factors, including the rising incidence rates of lung cancer, enhanced hospital surgical capabilities, the availability of proficient thoracic surgeons, the increasing adoption of video-assisted thoracoscopic surgery, and greater awareness of early-stage lung cancer treatment.
The lung cancer surgery market size is projected to experience consistent expansion over the upcoming years. This market is anticipated to reach $6.73 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.7%. Key drivers of this forecasted growth include the increasing incorporation of robotic surgery platforms, a heightened demand for precise surgical results, the proliferation of specialized cancer care facilities, rising capital expenditure in surgical technology, and the wider implementation of enhanced recovery after surgery protocols. Significant trends expected during this period involve the increasing embrace of minimally invasive surgical approaches, a rise in robotic-assisted thoracic surgery applications, a stronger inclination towards lung-sparing procedures, broadening utilization of advanced surgical instruments, and an increased emphasis on improving post-surgical recovery outcomes.
Get A Free Sample Report With In-Depth Market Insights:
Lung Cancer Surgery Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The rising occurrence of lung cancer is projected to drive expansion within the lung cancer surgery market. Lung cancer is defined by the unchecked proliferation of atypical cells in one or both lungs, potentially disrupting their proper function. This surge in lung cancer cases stems from extended exposure to air pollution, particularly fine particulate matter, as these microscopic particles are capable of permeating deeply into the lungs, resulting in inflammation, cellular harm, and genetic alterations that can foster cancer progression. Surgical intervention for lung cancer aids in lowering the fatality rate associated with the disease by facilitating the prompt excision of malignant tumors prior to their dissemination or advancement. As an illustration, in June 2025, data from the Centers for Disease Control and Prevention, a US-based federal government agency, indicated that in 2023, lung cancer caused 131,584 deaths in the United States, subsequent to 218,893 newly reported cases in 2022. Consequently, the growing frequency of lung cancer is stimulating the expansion of the lung cancer surgery market.
Lung Cancer Surgery Market Breakdown By Product Type And Application
The lung cancer surgery market covered in this report is segmented –
1) By Surgical Approach: Thoracotomy, Minimally Invasive Surgeries
2) By Procedure: Lobectomy, Segmentectomy, Pneumonectomy, Sleeve Resection, Extended Reserction
3) By Product: Thoracoscopes, Mediastinoscopes, Bronchoscopes, Robotic-Assistes Thoracic Surgery Systems, Surgical Staplers, Surgical Energy Instruments, Advanced Energy Instruments, Advanced Bipolar Instruments, Ultrasonic Instruments
4) By Distribution Channels: Direct Tender, Retail Sales, Online Sales, Other Channels
5) By End User: Hospitals, Ambulatory And Surgical Centres, Academic And Research Institutes, Specialiaty Cancer Care Centre, Other End Users
Subsegments:
1) By Thoracotomy: Lobectomy, Pneumonectomy, Segmentectomy, Wedge Resection
2) By Minimally Invasive Surgeries: Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery
Lung Cancer Surgery Market Innovation Trends Shaping Future Development
Leading companies within the lung cancer surgery market are concentrating on developing innovative technologies, such as robotic-assisted surgeries, to improve surgical accuracy, shorten recovery times, and enhance patient outcomes. Robotic-assisted surgeries involve minimally invasive procedures carried out by surgeons utilizing robotic systems to increase precision, lower complications, and better patient recovery. For instance, in March 2025, Johnson & Johnson MedTech, a US-based medical devices and technology company, announced the U.S. 510(k) regulatory clearance of MONARCH QUEST. The MONARCH QUEST robotic-assisted bronchoscopy platform offers enhanced reach and stability for accessing small, hard-to-reach lung nodules, thereby improving the ability to diagnose lung cancer in its earlier stages. Its advanced maneuverability and integration with imaging technologies enable more accurate biopsies while minimizing patient discomfort. Designed to expand procedural capabilities and streamline workflow, the platform supports greater clinical confidence and consistency across a broader spectrum of bronchoscopic procedures.
Lung Cancer Surgery Market Company Landscape And Competitive Strategy
Major companies operating in the lung cancer surgery market are Johnson And Johnson, Medtronic plc, Fujifilm Holdings Corporation, B Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc, Teleflex Incorporated, Karl Storz SE, Lepu Medical Technology Beijing Co Ltd, Ambu AS, KLS Martin Group, Richard Wolf GmbH, Ethicon Inc, Ackermann Instrument GmbH, Scanlan International Inc, Sontec Instruments Inc, Covidien LLC, Stryker Corporation, Smith And Nephew plc, CONMED Corporation, Erbe Elektromedizin GmbH
View The Full Lung Cancer Surgery Market Report:
Lung Cancer Surgery Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the lung cancer surgery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
